Page 3 - CUA Presentation

Overall Learning Objectives

At the conclusion of this program, participants should be able to:

Recognize the DNA Integrate genetic testing Describe the mechanism Explain the timing,
damage response (DDR) for patients with of action, efficacy, and monitoring, and

gene mutations that are prostate cancer into safety of PARP inhibitors management of
involved in prostate their clinical practice in order to employ these adverse events
cancer, and their agents for the treatment

implications for therapy of prostate cancer with
DDR mutations

DDR, DNA damage response; PARP, poly(ADP-ribose) polymerase